COLUMN GROUP II, LP - 30 Sep 2025 SCHEDULE 13G/A Report for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC)

Filing Manager: COLUMN GROUP II, LP
Reporting Manager: Peter Svennilson
Security: ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: ORIC
Shares outstanding: 98.5M shares
Disclosed Ownership: 3.64M shares
Ownership: 3.7%
Form type: SCHEDULE 13G/A
Filing time: 17 Nov 2025, 20:17:05 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
The Column Group II, LP	3.6%	3.54M	0	3.54M	/s/ James Evangelista, Attorney-in-Fact	James Evangelista, Attorney-in-Fact
The Column Group II GP, LP	3.6%	3.54M	0	3.54M	/s/ James Evangelista, Attorney-in-Fact	James Evangelista, Attorney-in-Fact
David V Goeddel	3.7%	3.63M	86.7K	3.54M	/s/ James Evangelista, Attorney-in-Fact	James Evangelista, Attorney-in-Fact
Peter Svennilson	3.7%	3.64M	103K	3.54M	/s/ James Evangelista, Attorney-in-Fact	James Evangelista, Attorney-in-Fact